Government secures coronavirus treatment drug with Zurich pharmaceutical company
The government says it has agreed with a Zurich based pharmaceutical company to secure 200,000 doses of a drug which could treat coronavirus victims.
It also has an option for a further three million doses.
The drug is not yet ready to be administered but is due to start human trials at the end of summer.
It’s been developed by Molecular Partners and is mainly for therapeutic use, but it maybe given to health care staff as a precaution.